Abstract Details
|
Nandhagopal Ramachandiran, MBBS, DM, FRCP, FAAN, FANA, FAAN
PRESENTER |
Dr. Ramachandiran has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| Arunodaya R. Gujjar, MBBS, DM, FRCP (Sultan Qaboos University, Muscat, Oman) | Dr. Gujjar has nothing to disclose. |
| Abdullah Al-Asmi, MD | No disclosure on file |
| Francesco Muntoni, MD (UCL Institute of Child Health) | Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee. |